Brett S. Spector
Directeur/Bestuurslid bij Fesariustherapeutics, Inc.
Profiel
Brett S.
Spector is currently a Director at Fesariustherapeutics, Inc. He was previously the President at SuttonBrook Capital Management LP from 2009 to 2012.
Actieve functies van Brett S. Spector
| Bedrijven | Functie | Begin |
|---|---|---|
Fesariustherapeutics, Inc.
 Fesariustherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fesariustherapeutics, Inc. is an American Brooklyn-based company that specializes in tissue repair biomaterial for reconstructive surgeons. The company's flagship product, Dermisphere™, is an intelligently patterned native-state hydrogel scaffold for dermal tissue regeneration. The scaffold is made of collagen microspheres incorporated in a self-assembling collagen hydrogel that provides an optimal environment for cells from surrounding healthy tissues to migrate into the hydrogel. The company was founded by Jason Spector, a renowned plastic surgeon, and has been led by CEO Thomas G. Roueche since 2021. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Brett S. Spector
| Bedrijven | Functie | Einde |
|---|---|---|
SuttonBrook Capital Management LP
 SuttonBrook Capital Management LP Investment ManagersFinance Founded in 2002, SuttonBrook Capital Management LLC is a hedge fund manager located in New York City. | Financieel Directeur/CFO | 01-04-2012 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
SuttonBrook Capital Management LP
SuttonBrook Capital Management LP Investment ManagersFinance Founded in 2002, SuttonBrook Capital Management LLC is a hedge fund manager located in New York City. | Finance |
Fesariustherapeutics, Inc.
Fesariustherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fesariustherapeutics, Inc. is an American Brooklyn-based company that specializes in tissue repair biomaterial for reconstructive surgeons. The company's flagship product, Dermisphere™, is an intelligently patterned native-state hydrogel scaffold for dermal tissue regeneration. The scaffold is made of collagen microspheres incorporated in a self-assembling collagen hydrogel that provides an optimal environment for cells from surrounding healthy tissues to migrate into the hydrogel. The company was founded by Jason Spector, a renowned plastic surgeon, and has been led by CEO Thomas G. Roueche since 2021. | Health Technology |
